• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马兜铃酸 I 和 II 的代谢研究。

Studies on the metabolism of aristolochic acids I and II.

作者信息

Krumbiegel G, Hallensleben J, Mennicke W H, Rittmann N, Roth H J

机构信息

Dr Madaus GmbH & Co., Department of Biochemistry, Cologne, Germany.

出版信息

Xenobiotica. 1987 Aug;17(8):981-91. doi: 10.3109/00498258709044197.

DOI:10.3109/00498258709044197
PMID:3673113
Abstract
  1. After oral administration of aristolochic acid I (AAI) and aristolochic acid II (AAII) to rats, the following metabolites were isolated from the urine and their structures elucidated: aristolactam I, aristolactam Ia, aristolochic acid Ia, aristolic acid I and 3,4-methylenedioxy-8-hydroxy-1-phenanthrenecarboxylic acid (metabolites of AAI); or aristolactam Ia, aristolactam II and 3,4-methylenedioxy-1-phenanthrenecarboxylic acid (metabolites of AAII). A further metabolite of AAII having a lactam structure has not yet been isolated in pure form. 2. The metabolic pathways have been elucidated by administration of various metabolites. 3. The principal metabolite of AAI in rats was aristolactam Ia; 46% of the dose was excreted in the urine in form of this metabolite and 37% in the faeces. The other substances were minor metabolites. Those metabolites of AAII whose structures have been elucidated were minor metabolites; the largest proportion consisted of aristolactam II, which accounted for 4.6% in the urine and 8.9% in the faeces. 4. The mouse was the only animal which had the same metabolite patterns of AAI and AAII as those found in the rat. Not all the metabolites listed above were found in urine from guinea pigs, rabbits, dogs and man.
摘要
  1. 给大鼠口服马兜铃酸I(AAI)和马兜铃酸II(AAII)后,从尿液中分离出以下代谢产物并阐明了其结构:马兜铃内酰胺I、马兜铃内酰胺Ia、马兜铃酸Ia、马兜铃酸I和3,4 - 亚甲二氧基 - 8 - 羟基 - 1 - 菲羧酸(AAI的代谢产物);或马兜铃内酰胺Ia、马兜铃内酰胺II和3,4 - 亚甲二氧基 - 1 - 菲羧酸(AAII的代谢产物)。尚未以纯形式分离出具有内酰胺结构的AAII的另一种代谢产物。2. 通过给予各种代谢产物阐明了代谢途径。3. AAI在大鼠体内的主要代谢产物是马兜铃内酰胺Ia;46%的剂量以该代谢产物的形式经尿液排出,37%经粪便排出。其他物质是次要代谢产物。已阐明结构的AAII的那些代谢产物是次要代谢产物;其中最大比例的是马兜铃内酰胺II,其在尿液中占4.6%,在粪便中占8.9%。4. 小鼠是唯一具有与大鼠中发现的AAI和AAII相同代谢产物模式的动物。豚鼠、兔子、狗和人的尿液中并未发现上述所有代谢产物。

相似文献

1
Studies on the metabolism of aristolochic acids I and II.马兜铃酸 I 和 II 的代谢研究。
Xenobiotica. 1987 Aug;17(8):981-91. doi: 10.3109/00498258709044197.
2
Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.采用不同色谱方法,通过³²P后标记分析法对大鼠靶器官(前胃)中由马兜铃酸形成的DNA加合物进行表征。
Carcinogenesis. 1994 Jun;15(6):1187-92. doi: 10.1093/carcin/15.6.1187.
3
Metabolism of Aristolochic Acid I and II in Rats Is Influenced by Their Coexposure.马兜铃酸 I 和 II 在大鼠体内的代谢受其共同暴露的影响。
Chem Res Toxicol. 2020 Nov 16;33(11):2804-2818. doi: 10.1021/acs.chemrestox.0c00198. Epub 2020 Oct 20.
4
Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.
Carcinogenesis. 1986 Jan;7(1):59-63. doi: 10.1093/carcin/7.1.59.
5
Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.马兜铃酸 I 的代谢产物马兜铃内酰胺 I 经活化后形成一种加合物,在中草药肾病患者的 DNA 中可发现该加合物。
Exp Toxicol Pathol. 1999 Jul;51(4-5):421-7. doi: 10.1016/S0940-2993(99)80033-5.
6
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.对服用含马兜铃酸的中药导致的中草药肾病患者组织中由马兜铃酸形成的DNA加合物进行32P后标记分析。
Carcinogenesis. 1997 May;18(5):1063-7. doi: 10.1093/carcin/18.5.1063.
7
Aristolochic acid I metabolism in the isolated perfused rat kidney.马兜铃酸 I 在离体灌流大鼠肾脏中的代谢。
Chem Res Toxicol. 2012 Jan 13;25(1):130-9. doi: 10.1021/tx200333g. Epub 2011 Dec 14.
8
Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.位点特异性马兜铃酸DNA加合物对人DNA聚合酶α体外DNA合成的影响。
Cancer Lett. 1995 Nov 27;98(1):47-56.
9
32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.马兜铃酸I和II形成的DNA加合物的32P后标记分析。
Carcinogenesis. 1990 Sep;11(9):1627-33. doi: 10.1093/carcin/11.9.1627.
10
Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.前列腺素H合酶对致癌马兜铃酸进行还原激活的证据——DNA加合物形成的(32)P后标记分析
Mutat Res. 2001 Jun 27;493(1-2):149-60. doi: 10.1016/s1383-5718(01)00171-1.

引用本文的文献

1
Untargeted DNA Adductomics Identifies Aristolochic Acid III as a Potent DNA-Damaging Agent among 11 Substituted Aromatic Genotoxicants in the Rat Urinary System.非靶向DNA加合物组学鉴定出马兜铃酸III是大鼠泌尿系统中11种取代芳香族基因毒性剂中的一种强效DNA损伤剂。
Chem Res Toxicol. 2025 Jul 21;38(7):1239-1256. doi: 10.1021/acs.chemrestox.5c00126. Epub 2025 Jun 16.
2
Absorptivity Is an Important Determinant in the Toxicity Difference between Aristolochic Acid I and Aristolochic Acid II.吸收系数是马兜铃酸I和马兜铃酸II毒性差异的重要决定因素。
J Agric Food Chem. 2025 Jan 29;73(4):2551-2561. doi: 10.1021/acs.jafc.4c10765. Epub 2025 Jan 14.
3
The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets.
铁死亡在急性肾损伤中的作用:机制与潜在治疗靶点
Mol Cell Biochem. 2025 Feb;480(2):759-784. doi: 10.1007/s11010-024-05056-3. Epub 2024 Jun 28.
4
Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy.肾血管紧张素 I 转换酶缺陷型小鼠对马兜铃酸肾病有保护作用。
Pflugers Arch. 2023 Mar;475(3):391-403. doi: 10.1007/s00424-022-02779-4. Epub 2022 Dec 15.
5
In-line formation and identification of toxic reductive metabolites of aristolochic acid using electrochemistry mass spectrometry coupling.使用电化学质谱联用技术在线形成和鉴定马兜铃酸的有毒还原代谢物。
Anal Bioanal Chem. 2022 Mar;414(7):2363-2370. doi: 10.1007/s00216-022-03874-2. Epub 2022 Jan 13.
6
Worldwide research trends on aristolochic acids (1957-2017): Suggestions for researchers.全球关于马兜铃酸(1957-2017)的研究趋势:对研究人员的建议。
PLoS One. 2019 May 2;14(5):e0216135. doi: 10.1371/journal.pone.0216135. eCollection 2019.
7
Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.人肝-肾模型阐明了马兜铃酸肾病的发病机制。
JCI Insight. 2017 Nov 16;2(22). doi: 10.1172/jci.insight.95978.
8
Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches.体外微粒体细胞色素P450对致癌性马兜铃酸I和II的氧化作用比较:实验和理论方法
Monatsh Chem. 2017;148(11):1971-1981. doi: 10.1007/s00706-017-2014-9. Epub 2017 Jul 26.
9
DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.马兜铃酸形成的 DNA 加合物是暴露的独特生物标志物,并解释了上尿路上皮癌的起始阶段。
Int J Mol Sci. 2017 Oct 14;18(10):2144. doi: 10.3390/ijms18102144.
10
An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.马兜铃酸肾病的综合观点:文献综述
Int J Mol Sci. 2017 Jan 29;18(2):297. doi: 10.3390/ijms18020297.